MDMA/MDA, Quantitative, Urine

Test Code

17161

CPT Codes
80359

Includes

MDA, MDMA, MDEA

Preferred Specimen

20 mL random urine collected in a plastic, leak-proof urine container

Minimum Volume

5 mL

Transport Temperature

Refrigerated (cold packs)

Specimen Stability

Room temperature: 14 days
Refrigerated: 14 days
Frozen: 30 days

Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)

Preserved urine

Methodology
Mass Spectrometry (MS)

FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Setup Schedule

Set up: Tues-Sat a.m.; Report available: 3 days

Reference Range

MDA	<200 ng/mL
MDMA	<200 ng/mL
MDEA	<200 ng/mL

Clinical Significance

This test is designed to detect the use of the stimulant/ hallucinogen Methylenedioxymethamphetamine (MDMA, XTC, Ecstasy) and its metabolite Methylenedioxyamphetamine (MDA).

Performing Laboratory
Quest Diagnostics Nichols Institute-Chantilly VA
14225 Newbrook Drive
Chantilly, VA 20151-2228

The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.